hrcak mascot   Srce   HID

Stručni rad

Treatment of Submacular Haemorrhage in Patients with Neovascular Age Related Macular Degeneration

Xhevat Lumi ; Eye Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia
Marko Šulak ; Eye Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia

Puni tekst: engleski, pdf (141 KB) str. 223-226 preuzimanja: 211* citiraj
APA 6th Edition
Lumi, X. i Šulak, M. (2013). Treatment of Submacular Haemorrhage in Patients with Neovascular Age Related Macular Degeneration. Collegium antropologicum, 37 Supplement 1 (1), 223-226. Preuzeto s https://hrcak.srce.hr/102894
MLA 8th Edition
Lumi, Xhevat i Marko Šulak. "Treatment of Submacular Haemorrhage in Patients with Neovascular Age Related Macular Degeneration." Collegium antropologicum, vol. 37 Supplement 1, br. 1, 2013, str. 223-226. https://hrcak.srce.hr/102894. Citirano 23.02.2020.
Chicago 17th Edition
Lumi, Xhevat i Marko Šulak. "Treatment of Submacular Haemorrhage in Patients with Neovascular Age Related Macular Degeneration." Collegium antropologicum 37 Supplement 1, br. 1 (2013): 223-226. https://hrcak.srce.hr/102894
Harvard
Lumi, X., i Šulak, M. (2013). 'Treatment of Submacular Haemorrhage in Patients with Neovascular Age Related Macular Degeneration', Collegium antropologicum, 37 Supplement 1(1), str. 223-226. Preuzeto s: https://hrcak.srce.hr/102894 (Datum pristupa: 23.02.2020.)
Vancouver
Lumi X, Šulak M. Treatment of Submacular Haemorrhage in Patients with Neovascular Age Related Macular Degeneration. Collegium antropologicum [Internet]. 2013 [pristupljeno 23.02.2020.];37 Supplement 1(1):223-226. Dostupno na: https://hrcak.srce.hr/102894
IEEE
X. Lumi i M. Šulak, "Treatment of Submacular Haemorrhage in Patients with Neovascular Age Related Macular Degeneration", Collegium antropologicum, vol.37 Supplement 1, br. 1, str. 223-226, 2013. [Online]. Dostupno na: https://hrcak.srce.hr/102894. [Citirano: 23.02.2020.]

Sažetak
To evaluate the efficacy of the pneumatic displacement of the submacular haemorrhage combined with the intravitreal injection of the tissue plasminogen activator. We present a retrospective clinical case series of nine eyes of nine patients that were treated with the intravitreal injection of the tissue plasminogen activator and expansile gas for the submacular haemorrhage due to the age related macular degeneration. We evaluated visual acuities and complications. Selected patients were additionally treated with the intravitreal bevacizumab injections after the procedure. Mean postoperative followup was 19 weeks. Four (4/9) eyes (44%) received additional treatment with the intravitreal bevacizumab
during the postoperative period. Statistical analysis was performed using the Student’s paired t-test. The mean visual acuity was 1.77 logMAR preoperatively and 1.06 logMAR postoperatively. After the surgery, 4 or more Snellen lines were gained in 7/9 eyes (78%). The improvement of the visual acuity postoperatively was statistically significant (p = 0.002). In 2/9 eyes (22%) the visual acuity did not get better after the procedure. We observed no complications during the follow up period. In our case series, pneumatic displacement of the submacular haemorrhage with the use of the intravitreal tissue
plasminogen activator (with or without additional bevacizumab treatment in the selected cases) turned out to be an effective and safe method leading to the improvement of the visual acuity in the majority of cases. To maximise the treatment success, prompt referral to the retinal surgeon is imperative.

Ključne riječi
submacular haemorrhage; age related macular degeneration; pneumatic displacement; tissue plasminogen activator; bevacizumab; visual acuity

Hrčak ID: 102894

URI
https://hrcak.srce.hr/102894

Posjeta: 334 *